Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Show me how to use this page

SELLAS Life Sciences Group Inc Stock

Price
Target price
€1.16

€1.16

1.230%
0.014
1.230%
-
 
22:26 / Tradegate WKN: A2PU3T / Symbol: RXII / Name: SELLAS Life Sciences / Stock / Pharmaceuticals / Micro Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of SELLAS Life Sciences Group Inc in the next few years
Wizard

Description SELLAS Life Sciences

SELLAS Life Sciences is a clinical-stage biopharmaceutical company that specializes in the development of cancer immunotherapies. The company's lead product candidate, galinpepimut-S (GPS), is a peptide-based immunotherapy that targets a specific protein found in various cancers, including acute myeloid leukemia, malignant pleural mesothelioma, and multiple myeloma.

SELLAS also has a second product candidate, nelipepimut-S (NPS), which is a cancer vaccine designed to activate the immune system against tumors that express the HER2/neu oncogene. The vaccine has shown promise in early-stage clinical trials for the treatment of breast cancer.

SELLAS is listed on the NASDAQ Global Market under the symbol RXII, and as of April 2021, had a market capitalization of approximately $67 million.

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock SELLAS Life Sciences Group Inc is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for SELLAS Life Sciences

sharewise wants to provide you with the best news and tools for SELLAS Life Sciences, so we directly link to the best financial data sources.

Financials

News

Broker